Related Experiment Video
Updated: Oct 30, 2025

Author Spotlight: Enhancing Transplantation Research Through MicroCT Angiography in Murine Models
Published on: September 22, 2023
Fungal Infections in Liver Transplant Recipients
Michael Scolarici1, Margaret Jorgenson2, Christopher Saddler1
1Department of Medicine, University of Wisconsin, Madison, WI 53792, USA.
Abstract:
Invasive fungal infections (IFIs) are one of the most feared complications associated with liver transplantation, with high rates of morbidity and mortality. We discuss the most common invasive fungal infections in the setting of liver transplant, including Candida, Aspergillus, and Cryptococcal infections, and some less frequent but devastating mold infections. Further, we evaluate the use of prophylaxis to prevent invasive fungal infection in this population as a promising mechanism to reduce risks to patients after liver transplant.
Insights
Invasive fungal infections (IFIs) pose significant risks after liver transplantation. Prophylaxis strategies are crucial for preventing these serious infections and improving patient outcomes.
Area of Science:
- * Medical Mycology
- * Transplantation Medicine
- * Infectious Diseases
Background:
- * Invasive fungal infections (IFIs) are a major cause of morbidity and mortality in liver transplant recipients.
- * Common IFIs include Candida, Aspergillus, and Cryptococcal infections, alongside rarer but severe mold infections.
Purpose of the Study:
- * To review common and less frequent invasive fungal infections in liver transplant patients.
- * To evaluate the role of antifungal prophylaxis in mitigating IFIs post-transplant.
Main Methods:
- * Literature review and synthesis of existing data on IFIs in liver transplantation.
- * Analysis of current prophylaxis strategies and their effectiveness.
Main Results:
- * Candida, Aspergillus, and Cryptococcal species are the most prevalent fungal pathogens.
- * Certain mold infections present a significant, albeit less frequent, threat.
- * Antifungal prophylaxis shows promise in reducing IFI incidence.
Conclusions:
- * IFIs represent a critical challenge in liver transplant care.
- * Prophylactic antifungal administration is a key strategy to improve patient safety and reduce IFI-related complications.
Related Concept Videos
Kidney Transplant III: Nursing Management
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure
Kidney Transplant I: Introduction
Fungal Phylum Microsporidia
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

